Exploring the intention and hesitancy to receive a booster dose of COVID-19 vaccine among patients with comorbid disease conditions using a health belief model

Q3 Medicine

Vacunas Pub Date : 2023-10-01 DOI:10.1016/j.vacun.2023.06.006

Anmar Al-Taie , Zekiye Yilmaz

{"title":"Exploring the intention and hesitancy to receive a booster dose of COVID-19 vaccine among patients with comorbid disease conditions using a health belief model","authors":"Anmar Al-Taie , Zekiye Yilmaz","doi":"10.1016/j.vacun.2023.06.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Despite the fact that the WHO recommends that adults over the age of 18 have to receive a booster dose of the COVID-19 vaccine. The willingness and intention to accept a booster dose of the COVID-19 vaccine remain major issues among the general population, particularly patients with comorbid disease conditions. The aim of this study was to assess the patterns regarding COVID-19 infection and vaccination, along with the intention and hesitancy to receive a booster dose of the COVID-19 vaccine among patients with comorbid disease conditions in Istanbul, Türkiye.</p></div><div><h3>Methods</h3><p>This was a descriptive, cross-sectional study conducted among patients with comorbid disease conditions using a three-part, structured, validated questionnaire. Vaccine hesitancy from a booster dose of the COVID-19 vaccine was assessed using the Health Belief Model (HBM), based on a 5-point Likert-type scale.</p></div><div><h3>Results</h3><p>The study enrolled 162 participants with a mean age of 57.2 ± 13.3 years. 97% of the respondents received the COVID-19 vaccine. Almost half of respondents (51.2%) reported receiving information about a booster dose of the COVID-19 vaccine. HBM among the participants with comorbidities showed a significant agreement regarding the perceived susceptibility (P < 0.0001), perceived severity (P < 0.0001) and perceived benefits (P < 0.0001) to receive a booster vaccine dose. There was a statistically significant correlation between the intention to receive a booster vaccine dose and education level (university education; P < 0.0001).</p></div><div><h3>Conclusion</h3><p>A vast and significant majority of patients with chronic comorbid disease conditions who received the COVID-19 vaccine reported an intention to receive a booster dose.</p></div>","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1576988723000560/pdfft?md5=d3aefaf67debbc887f427846443ca254&pid=1-s2.0-S1576988723000560-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vacunas","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1576988723000560","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Despite the fact that the WHO recommends that adults over the age of 18 have to receive a booster dose of the COVID-19 vaccine. The willingness and intention to accept a booster dose of the COVID-19 vaccine remain major issues among the general population, particularly patients with comorbid disease conditions. The aim of this study was to assess the patterns regarding COVID-19 infection and vaccination, along with the intention and hesitancy to receive a booster dose of the COVID-19 vaccine among patients with comorbid disease conditions in Istanbul, Türkiye.

Methods

This was a descriptive, cross-sectional study conducted among patients with comorbid disease conditions using a three-part, structured, validated questionnaire. Vaccine hesitancy from a booster dose of the COVID-19 vaccine was assessed using the Health Belief Model (HBM), based on a 5-point Likert-type scale.

Results

The study enrolled 162 participants with a mean age of 57.2 ± 13.3 years. 97% of the respondents received the COVID-19 vaccine. Almost half of respondents (51.2%) reported receiving information about a booster dose of the COVID-19 vaccine. HBM among the participants with comorbidities showed a significant agreement regarding the perceived susceptibility (P < 0.0001), perceived severity (P < 0.0001) and perceived benefits (P < 0.0001) to receive a booster vaccine dose. There was a statistically significant correlation between the intention to receive a booster vaccine dose and education level (university education; P < 0.0001).

Conclusion

A vast and significant majority of patients with chronic comorbid disease conditions who received the COVID-19 vaccine reported an intention to receive a booster dose.

查看原文本刊更多论文

利用健康信念模型探讨合并疾病患者接受新冠肺炎疫苗加强剂的意愿和犹豫

尽管世界卫生组织建议18岁以上的成年人必须接种加强剂量的COVID-19疫苗。接受COVID-19疫苗加强剂的意愿和意图仍然是普通人群，特别是患有合并症疾病的患者的主要问题。本研究的目的是评估土耳其伊斯坦布尔患有合并症的患者中COVID-19感染和疫苗接种的模式，以及接受加强剂COVID-19疫苗的意愿和犹豫。方法:这是一项描述性、横断面研究，采用三部分、结构化、有效的问卷调查，在患有合并症的患者中进行。使用基于5点李克特量表的健康信念模型(HBM)评估COVID-19疫苗加强剂的疫苗犹豫。结果共纳入162名参与者，平均年龄为57.2 ± 13.3 岁。97%的受访者接种了COVID-19疫苗。近一半的答复者(51.2%)报告收到了关于COVID-19疫苗加强剂的信息。在有合并症的参与者中，HBM在接受加强疫苗剂量的感知易感性(P < 0.0001)、感知严重性(P < 0.0001)和感知益处(P < 0.0001)方面显示出显著的一致性。接受加强疫苗剂量的意愿与教育水平(大学教育程度;P & lt; 0.0001)。结论绝大多数接受COVID-19疫苗的慢性合并症患者报告有意接受加强剂量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vacunas Medicine-Infectious Diseases

CiteScore

3.90

自引率

0.00%

发文量

138

审稿时长

62 days

期刊介绍： Sin duda una de las mejores publicaciones para conocer los avances en el campo de las vacunaciones preventivas, tanto en el ámbito de la investigación básica como aplicada y en la evaluación de programas de vacunaciones. Su alta calidad y utilidad la ha llevado a estar indexada en los prestigiosos índices IME y SCOPUS.